1-1 of 1
Chris Conrad
Close
Sort by
Journal Articles

Identification of apilimod as a first-in-class PIKfyve kinase inhibitor for treatment of B-cell non-Hodgkin lymphoma

Sophia Gayle, Sean Landrette, Neil Beeharry, Chris Conrad, Marylens Hernandez, Paul Beckett, Shawn M. Ferguson, Talya Mandelkern, Meiling Zheng, Tian Xu, Jonathan Rothberg, Henri Lichenstein
Journal: Blood
Blood (2017) 129 (13): 1768–1778.
https://doi.org/10.1182/blood-2016-09-736892
Published: 2017
Includes: Supplemental data